XTANT MEDICAL HOLDINGS, INC. (XTNT) Gross Margin
- Gross margin · 12 months: Value 59.39%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 59.39% | Gross profit / revenue. Period ending 2026-06-30. $65.05M ÷ $109.53M × 100 ≈ 59.39% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 65.05M USD | Gross Profit |
| Revenue | 109.53M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 44.48M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $65.05M | $109.53M | $44.48M | 59.39% |
| 2026-03-31 | $76.00M | $121.91M | $45.91M | 62.34% |
| 2025-12-31 | $84.27M | $133.93M | $49.65M | 62.92% |
| 2025-09-30 | $82.54M | $133.08M | $50.54M | 62.02% |
| 2025-06-30 | $76.86M | $127.77M | $50.91M | 60.16% |
| 2025-03-31 | $71.16M | $122.30M | $51.14M | 58.18% |
| 2024-12-31 | $68.22M | $117.27M | $49.05M | 58.17% |
| 2024-09-30 | $69.33M | $113.86M | $44.53M | 60.89% |
| 2024-06-30 | $68.36M | $110.94M | $42.59M | 61.61% |
| 2024-03-31 | $62.23M | $101.23M | $39.00M | 61.48% |
| 2023-12-31 | $55.47M | $91.30M | $35.84M | 60.75% |
| 2023-09-30 | $46.64M | $78.47M | $31.83M | 59.44% |
| 2023-06-30 | $39.20M | $67.91M | $28.71M | 57.72% |
| 2023-03-31 | $35.11M | $62.95M | $27.84M | 55.78% |
| 2022-12-31 | $32.14M | $57.97M | $25.83M | 55.44% |
| 2022-09-30 | $31.53M | $56.67M | $25.14M | 55.63% |
| 2022-06-30 | $30.82M | $55.98M | $25.16M | 55.05% |
| 2022-03-31 | $31.96M | $55.68M | $23.72M | 57.40% |
| 2021-12-31 | $32.49M | $55.26M | $22.77M | 58.79% |
| 2021-09-30 | $33.78M | $55.31M | $21.53M | 61.07% |
| 2021-06-30 | $35.84M | $55.55M | $19.71M | 64.51% |
| 2021-03-31 | $32.87M | $51.10M | $18.23M | 64.32% |
| 2020-12-31 | $34.39M | $53.34M | $18.95M | 64.48% |
| 2020-09-30 | $36.82M | $56.29M | $19.47M | 65.42% |
| 2020-06-30 | $37.96M | $57.99M | $20.03M | 65.46% |
| 2020-03-31 | $41.32M | $62.73M | $21.42M | 65.86% |
| 2019-12-31 | $42.52M | $64.68M | $22.17M | 65.73% |
| 2019-09-30 | $38.45M | $65.98M | $27.53M | 58.27% |
| 2019-06-30 | $39.50M | $67.53M | $28.03M | 58.49% |
| 2019-03-31 | $42.07M | $71.00M | $28.93M | 59.25% |
| 2018-12-31 | $43.49M | $72.20M | $28.72M | 60.23% |
| 2018-09-30 | $46.52M | (m) | $26.75M | (m) |
| 2018-06-30 | $46.37M | (m) | $29.42M | (m) |
| 2018-03-31 | $47.43M | $78.46M | $31.04M | 60.44% |
| 2017-12-31 | $50.10M | $82.61M | $32.51M | 60.65% |
| 2017-09-30 | $57.32M | $87.75M | $30.43M | 65.32% |
| 2017-06-30 | $62.54M | $91.05M | $28.51M | 68.69% |
| 2017-03-31 | $63.72M | $91.11M | $27.39M | 69.94% |
| 2016-12-31 | $62.29M | $90.00M | $27.71M | 69.21% |
| 2016-09-30 | $59.66M | $87.79M | $28.13M | 67.96% |
| 2016-06-30 | $55.34M | $82.39M | $27.05M | 67.17% |
| 2016-03-31 | $47.15M | $70.82M | $23.67M | 66.58% |
| 2015-12-31 | $39.08M | $59.35M | $20.26M | 65.86% |
| 2015-09-30 | $29.97M | $46.17M | $16.20M | 64.91% |
| 2015-06-30 | $23.75M | $36.93M | $13.18M | 64.31% |
| 2015-03-31 | $22.83M | $35.92M | $13.10M | 63.54% |
| 2014-12-31 | $22.30M | $35.33M | $13.03M | 63.11% |
| 2014-09-30 | $20.62M | $34.51M | $13.89M | 59.74% |
| 2014-06-30 | $19.79M | $33.98M | $14.19M | 58.24% |
| 2014-03-31 | $18.89M | $33.37M | $14.48M | 56.62% |
| 2013-12-31 | $18.89M | $33.07M | $14.19M | 57.11% |
| 2013-09-30 | $19.38M | $32.94M | $13.56M | 58.83% |
| 2013-06-30 | $21.04M | $33.89M | $12.84M | 62.10% |
| 2013-03-31 | $22.23M | $33.83M | $11.60M | 65.71% |
| 2012-12-31 | $22.64M | $32.98M | $10.34M | 68.66% |
| 2012-09-30 | $22.11M | (m) | (m) | (m) |
| 2012-06-30 | $22.05M | (m) | (m) | (m) |
| 2012-03-31 | $21.94M | (m) | (m) | (m) |
| 2011-12-31 | $21.04M | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $12.05M | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |